CLXClorox
The Clorox Company is a leading multinational manufacturer and marketer of consumer and professional products with fiscal year 2026 net sales of $6.7 billion and about 9,200 employees worldwide as of June 30, 2026. 10-K, Item 1
- Employees
- 9,200
- Headquarters
- Oakland, CA
- CEO
- Linda J. Rendle
- Next results
- around Feb 2, 2027
What CLX's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Facts only; most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans adopted or ended
1 plan still running: Kirsten Marriner.
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Kirsten Marriner executive vice president - chief people and corporate affairs officer |
Adopted 10b5-1 plan | Dec 9, 2024 | up to 8,227 | Mar 2, 2027 | 10-Q Feb 3, 2025 |
The company's descriptionOn December 9, 2024, Kirsten Marriner, executive vice president - chief people and corporate affairs officer, entered into a trading plan designed to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The plan provides for the potential exercise and sale of up to 48,911 options and up to 8,227 shares of the Company’s common stock between March 10, 2025 and March 2, 2027. | |||||
| Angela Hilt EVP – Chief Legal Officer |
Adopted 10b5-1 plan | Jun 7, 2024 | up to 1,733 | Jun 6, 2025 | 10-K Aug 8, 2024 |
The company's descriptionOn June 7, 2024, Angela Hilt, EVP – Chief Legal Officer, entered into a trading plan designed to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The plan provides for sales of up to 1,733 shares of the Company's common stock. The plan also provides for the sale of up to 25% of shares of restricted stock units and performance units vesting during the duration of the plan, excluding any shares withheld by the Company to satisfy income tax withholding remittance obligations. Ms. Hilt’s plan begins on September 6, 2024 and ends June 6, 2025 or when all of the shares have been sold. | |||||
| Kirsten Marriner executive vice president – chief people and corporate affairs officer |
Adopted 10b5-1 plan | Jun 2, 2023 | up to 48,911 | 366 days | 10-K Aug 10, 2023 |
The company's descriptionOn June 2, 2023, Kirsten Marriner, executive vice president – chief people and corporate affairs officer, entered into a trading plan designed to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The plan provides for the potential exercise and sale of up to 48,911 options between August 31, 2023 and August 31, 2024. | |||||
| Kevin Jacobsen executive vice president – chief financial officer |
Adopted 10b5-1 plan | May 4, 2023 | up to 3,346 | 366 days | 10-K Aug 10, 2023 |
The company's descriptionOn May 4, 2023, Kevin Jacobsen, executive vice president – chief financial officer, entered into a trading plan designed to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The plan provides for sales of up to 3,346 shares of the Company's common stock beginning on August 14, 2023 and ending August 14, 2024 or when all of the shares have been sold. | |||||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 2, 2023.
Form 144 notices of planned sales
No Form 144 notices downloaded.
From the Form 144 XML filed with the SEC. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Work on CLX in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/CLX/export.csv") into a cell.